Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 18.70 INR
Change Today -0.20 / -1.06%
Volume 511.4K
SBML On Other Exchanges
SBML is not on other exchanges.
As of 7:06 AM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

sharon bio-medicine ltd (SBML) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/15/14 - 90.35
52 Week Low
02/27/15 - 15.40
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SHARON BIO-MEDICINE LTD (SBML)

Related News

No related news articles were found.

sharon bio-medicine ltd (SBML) Related Businessweek News

No Related Businessweek News Found

sharon bio-medicine ltd (SBML) Details

Sharon Bio-Medicine Limited develops, manufactures, and sells intermediates, active pharmaceutical ingredients (APIs), and finished dosage products in India and internationally. The company provides its APIs in a range of therapeutic areas, including anti depressant, anti hypertensive, anti fungal, anti diabetic, anti bacterial, anti Alzheimer, anti psychotic, anti protozoal, anti diarrhoeal, and cardiovascular areas, as well as veterinary, pro-kinetic, NSAID, and muscle relaxation areas. Its intermediate product line targets various API/end uses, such as ketoconazole, itraconazole, phase transfer catalyst, lansoprazole, trimetazidine, chemical synthesis, glibenclamide, glimepiride, amlodipine besylate, and sertraline HCL. The company also offers formulations in the therapeutic segments of oncology, antibiotics, dermatology, liquid orals, soft gelatin capsules, and suppositories. In addition, it provides clinical services, as well as various toxicology services related to animals. Sharon Bio-Medicine Limited was incorporated in 1989 and is based in Mumbai, India.

Founded in 1989

sharon bio-medicine ltd (SBML) Top Compensated Officers

Chairman and Managing Director
Total Annual Compensation: 2.8M
Director of Operations & Business Development...
Total Annual Compensation: 2.8M
Compensation as of Fiscal Year 2014.

sharon bio-medicine ltd (SBML) Key Developments

Sharon Bio-Medicine Ltd. Announces Resignation of Directors

Sharon Bio-Medicine Ltd. has informed that Mr. Vijay Kirpalani and Mr. Asif Rangwala has resigned as the Directors of the company, effective March 24, 2015.

Sharon Bio Medicine Limited Announces Resignation of Directors

Sharon Bio Medicine Limited announced that Mr. Vijay Kirpalani and Mr. Asif Rengwala has resigned as the Directors of the company with effect from 24th March, 2015.

Sharon Bio Medicine Limited, Board Meeting, Mar 30, 2015

Sharon Bio Medicine Limited, Board Meeting, Mar 30, 2015. Agenda: To approve allotment of equity shares on account of conversion of warrants.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SBML:IN 18.70 INR -0.20

SBML Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SBML.
View Industry Companies

Industry Analysis


Industry Average

Valuation SBML Industry Range
No financial data is available for SBML.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHARON BIO-MEDICINE LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at